Allovir, INC Form 4 insider transactions

Allovir's CEO, Diana Brainard, sold shares to cover tax withholding obligations related to the vesting of restricted stock units.

Vikas Sinha, CFO of Allovir, sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Brett R. Hagen, Chief Accounting Officer of Allovir, Inc., sold shares to cover tax withholding obligations related to vesting restricted stock units.

Edward Miller, General Counsel of Allovir, Inc., sold shares to cover tax withholding obligations related to vesting restricted stock units.

Vikas Sinha, CFO of Allovir, sold 940 shares of common stock on October 3, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Edward Miller, General Counsel of Allovir Inc., sold 377 shares of common stock on October 3, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Allovir's CEO, Diana Brainard, sold 1,493 shares of common stock on October 3, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Brett R. Hagen, Chief Accounting Officer of Allovir, Inc., sold 301 shares of common stock on October 3, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Allovir's CEO, Diana Brainard, sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Edward Miller, General Counsel of Allovir, Inc., sold 422 shares of common stock on August 19, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Vikas Sinha, CFO of Allovir, sold 3,159 shares of common stock on August 19, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Chief Accounting Officer of Allovir, Inc., Brett R Hagen, sold 544 shares of common stock on August 19, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Allovir's CEO, Diana Brainard, sold shares of common stock on August 19, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.

Edward Miller, General Counsel of Allovir, Inc., sold 2,323 shares of common stock on August 5, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Allovir's CEO, Diana Brainard, sold shares of common stock on August 5, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Chief Accounting Officer Hagen Brett R of Allovir, Inc. sold 1,692 shares of common stock on August 5, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Vikas Sinha, CFO of Allovir, sold 5,251 shares of common stock on August 5, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Chief Accounting Officer of Allovir, Inc., Brett R. Hagen, reports selling shares to cover tax withholding obligations related to vesting restricted stock units.

Allovir's CEO, Diana Brainard, sold shares of common stock on July 19, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.

Vikas Sinha, CFO of Allovir, Inc., sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Edward Miller, General Counsel of Allovir Inc., sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Edward Miller, General Counsel of Allovir, Inc., sold 379 shares of common stock on July 2, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Vikas Sinha, President and CFO of Allovir, Inc., reports the sale of shares to cover tax withholding obligations related to vesting restricted stock units, along with other holdings.

Brett R. Hagen, Chief Accounting Officer of Allovir, Inc., reports selling 304 shares of common stock on July 2, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Allovir's CEO, Diana Brainard, sold 1,489 shares of common stock on July 2, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.

Director Morana Jovan-Embiricos of Allovir, Inc. reports the acquisition of 35,000 restricted stock units (RSUs) and indirect beneficial ownership of millions of shares through various entities.

David Hallal, a director of Allovir, Inc., acquired 35,000 restricted stock units on June 6, 2024, according to a recent SEC filing.

Director Derek N. Adams acquired 35,000 Restricted Stock Units (RSUs) in Allovir, Inc. on June 6, 2024, according to a Form 4 filing.

Director Malcolm Brenner of Allovir, Inc. reports the acquisition of 35,000 Restricted Stock Units (RSUs) and indirect ownership of 163,732 shares held by The Malcolm and Cliona Brenner Revocable Trust.

Director Jeffrey S. Bornstein acquired 35,000 Restricted Stock Units (RSUs) in Allovir, Inc. on June 6, 2024, according to a recent SEC filing.